Trials / Sponsors / Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa Retinitis Pigmentosa | Phase 2 | 2025-08-29 |
| Recruiting | Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema Macular Edema | Phase 2 | 2025-05-01 |
| Terminated | A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Dry Eye Disease | Phase 2 | 2023-03-15 |
| Recruiting | A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitre Retinitis Pigmentosa, Choroideremia, Non-Syndromic Rod-Dominant Inherited Retinal Diseases | Phase 1 / Phase 2 | 2022-11-10 |
| Completed | A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects Persistent Corneal Epithelial Defect | Phase 2 | 2022-07-01 |